Levosalbutamol

BioDrugs

Volumn 11, Issue 6, 1999, Pages 431-438

  Ormrod, Douglas ^a   Spencer, Caroline M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LEVALBUTEROL; PLACEBO; SALBUTAMOL; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NERVOUSNESS; PRIORITY JOURNAL; RACEMIC MIXTURE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; TACHYCARDIA; TREMOR;

EID: 0032980242     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199911060-00007     Document Type: Review

References (20)

1. 1. Price AH, Clissold SP. Salbutamol in the 1980s. A reapprasial of its clinical efficacy. Drugs 1989; 38 (1): 77-122
2. 2. Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993 Oct 2; 342: 833-7
3. 3. Cockcroft DW, O'Byrne PM, Swystun VA, et al. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J Allergy Clin Immunol 1995 Jul; 96 (1): 44-9
4. 4. Iud PW. Salbutamol enantiomers: early clinical evidence in humans. Thorax 1997 Oct; 52: 839-40
5. 2-selective sympathomimetics. Pulm Pharmacol 1994 Dec; 7: 367-76
6. 6. Johansson F, Rydberg I, Aberg G, et al. Effects of albuterol enatomers on in vitro bronchial activity. Clin Rev Allergy Immunol 1996; 14: 57-64
7. 7. Perrin-Fayolle M. Salbutamol in the treatment of asthma [letter]. Lancet 1995 Oct 21; 346: 1101
8. 8. Prior C, Leonard MB, McCullough JR. Effects of the enantiomers of R,S-salbutamol on incompletely fused tetanic contractions of slow- and fast-twitch skeletal muscles of the guinea-pig. Br J Pharmacol 1998 Feb; 123: 558-64
9. 9. Mitra S, Ugur M, Ugur O, et al. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998 Mar; 53: 347-54
10. 10. Erjefalt J, Persson CGA. Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991; 143: 1008-14
11. 11. Basran GS, Paul W, Morley J, et al. Adrenoceptor-agonist inhibition of the histamine-induced cutaneous response in man. Br J Dermatol 1982; 107 Suppl. 23: 140-2
12. 12. Volcheck GW, Gleich GJ, Kita H. Pro- and anti-inflammatory effects of beta adrenergic agonists on eosinophil response to IL-5 [abstract]. J Allergy Clin Immunol 1998; 101 (1Pt 2): S35
13. 13. Gumbhir-Shah K, Kellerman DJ, De Graw S, et al. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. J Clin Pharmacol 1998 Dec; 38: 1096-106
14. 2adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. Thorax 1997 Oct; 52: 849-52
15. 15. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998 Dee; 102 (6 Pt 1): 943-52
16. 16. Cockcroft DW, Swystun VA. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997 Oct; 52: 845-8
17. 17. Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996 Jan; 41: 35-40
18. 18. Pleskow W, Nelson H, Kemp J. Improved secondary efficacy endpoints with levalbuterol (Xopenex™) vs racemic albutetol [abstract]. Ann Allergy Asthma Immunol 1999 Jan; 82 (1): 100
19. 19. Busse WW, Greos WI, Vaiekus L. Lower doses of Xopenex™ (levalbuterol) are as effective as racemic albuterol in the prevention of exercised induced bronchospasm (EIB) [abstract]. J Allergy Clin Immunol 1999; 103 (1 Pt 2): S136
20. 20. Gawchik SM, Saccar CL, Noonan M, et al. The safety and efficacy of nebulized levalbuteral compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 1999 Apr; 103: 615-21